by John Conrad | Jul 19, 2024 | NewsBrief
In a strategic move to expand its specialty biopharmaceuticals portfolio, Meitheal Pharmaceuticals has acquired the North American rights to CONTEPO™ (fosfomycin for injection) from Nabriva Therapeutics. The announcement, made on July 18, 2024, marks a significant...
by John Conrad | Jul 8, 2024 | NewsBrief
The heart of Illinois is set to become a global leader in biomanufacturing, thanks to a significant $51 million federal grant awarded to the Illinois Fermentation and Agriculture Biomanufacturing (iFAB) Tech Hub. This exciting development promises to transform the...
by John Conrad | Jun 28, 2024 | NewsBrief
AbbVie continues to bolster its immunology portfolio beyond Humira, announcing on Thursday its acquisition of early-stage biotech Celsius Therapeutics for $250 million in cash. This move aims to strengthen AbbVie’s longer-term prospects in inflammatory bowel...
by John Conrad | Jun 18, 2024 | iBIO News
iBIO Adds Accomplished Communications and Manufacturing Leaders to Board of Directors CHICAGO (June 18, 2024) The Illinois Biotechnology Innovation Organization (iBIO), the trade association representing the 91,000 jobs in Illinois’ life sciences sector, today...
by John Conrad | Jun 13, 2024 | iBIO News
With just a week to go, the excitement is building for the iBIO Timothy P. Walbert Entrepreneurship Impact Award Competition finals on June 20th at Fulton Market Aberdeen. Six trailblazing companies are set to showcase their groundbreaking innovations in biotech,...
